Skip Nav Destination
Issues
1 January 1999
ISSN 1078-0432
EISSN 1557-3265
Editorial
Advances in Brief
Treatment with Farnesyl-Protein Transferase Inhibitor Induces Regression of Mammary Tumors in Transforming Growth Factor (TGF) α and TGFα/neu Transgenic Mice by Inhibition of Mitogenic Activity and Induction of Apoptosis1
Peter Nørgaard; Brian Law; Heather Joseph; David L. Page; Yu Shyr; Debbie Mays; Jennifer A. Pietenpol; Nancy E. Kohl; Allen Oliff; Robert J. Coffey, Jr.; Hans Skovgaard Poulsen; Harold L. Moses
Clinical Trials
A Comparison of Clinical Pharmacodynamics of Different Administration Schedules of Oral Topotecan (Hycamtin)
Cees J. H. Gerrits; Jan H. M. Schellens; Howard Burris; John R. Eckardt; Andre S. T. Planting; Maria E. L. van der Burg; Gail I. Rodriguez; Walter J. Loos; Vera van Beurden; Ian Hudson; Daniel D. Von Hoff; Jaap Verweij
Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates1
Paul A. Vasey; Stan B. Kaye; Rosemary Morrison; Chris Twelves; Peter Wilson; Ruth Duncan; Alison H. Thomson; Lilian S. Murray; Tom E. Hilditch; Tom Murray; Sally Burtles; D. Fraier; E. Frigerio; Jim Cassidy; on behalf of the Cancer Research Campaign Phase I/II Committee
Hepatic Transcatheter Arterial Chemoembolization Alternating with Systemic Protracted Continuous Infusion 5-Fluorouracil for Gastrointestinal Malignancies Metastatic to Liver: A Phase II Trial of the Puget Sound Oncology Consortium (PSOC 1104)1
Linda M. Bavisotto; Nilesh H. Patel; Sandra J. Althaus; Douglas M. Coldwell; Hanh V. Nghiem; Tove Thompson; Barry Storer; Charles R. Thomas, Jr.
Molecular Oncology, Markers, Clinical Correlates
Thrombospondins I and II Messenger RNA Expression in Lung Carcinoma: Relationship with p53 Alterations, Angiogenic Growth Factors, and Vascular Density1
Gabriella Fontanini; Laura Boldrini; Alessandra Calcinai; Silvana Chinè; Marco Lucchi; Alfredo Mussi; Carlo Alberto Angeletti; Fulvio Basolo; Generoso Bevilacqua
Experimental Therapeutics, Preclinical Pharmacology
Attenuation of WAF1/Cip1 Expression by an Antisense Adenovirus Expression Vector Sensitizes Glioblastoma Cells to Apoptosis Induced by Chemotherapeutic Agents 1,3-Bis(2-chloroethyl)-1-nitrosourea and Cisplatin1
Sanbao Ruan; M. Fatih Okcu; Rey-Chen Pong; Michael Andreeff; Victor Levin; Jer-Tsong Hsieh; Wei Zhang
Errata
Advertisement
